Peripheral mechanisms in the control of appetite and related experimental therapies in obesity
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The function of the stomach and the gut hormonal responses to food ingestion constitute highly integrated homeostatic responses that maintain euglycemia and normal digestion. This intrinsic feedback involves vagal and hormonal mechanisms. Important signals such as GLP-1 and PYY that arise peripherally induce satiation and also delay gastric emptying or increase insulin secretion. Novel therapies are being developed to mimic or enhance these feedback mechanisms and to control appetite as a means to treat obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604 · cited 2×
“After the demonstrations that PYY retards gastric emptying of a liquid meal [4], reduces calorie intake and feeling of hunger [32], and administration of PYY3–36 reduced calorie intake in lean and obese participants [18], there was considerable interest in the potential for Camilleri Page 3”
BackgroundResultLong term pharmacotherapy for obesity and overweight: updated meta-analysis
Rucker, D., Padwal, R., Li, S. K., Curioni, C., & Lau, D. C. W. (2007) · BMJ · doi:10.1136/bmj.39385.413113.25 · Cited by 801
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass
le Roux, C. W., Welbourn, R., Werling, M., Osborne, A., Kokkinos, A., Laurenius, A., Lönroth, H., Fändriks, L., Ghatei, M. A., Bloom, S. R., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180caa3e3 · Cited by 741 · cited 8×
“The consistent findings are: reduced ghrelin (if part of stomach resected or out of contact with ingested nutrient), and early appearance and higher values of glucose counterregulatory hormones (like insulin, GIP, and GLP-1) and ileal hormones involved in the ileal brake, predominantly PYY [20].”
BackgroundInfluentialSubcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects
Wynne, K., Park, A. J., Small, C. J., Patterson, M., Ellis, S. M., Murphy, K. G., Wren, A. M., Frost, G. S., Meeran, K., Ghatei, M. A., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2390 · Cited by 435
Delgado-Aros, S., Kim, D.-Y., Burton, D. D., Thomforde, G. M., Stephens, D., Brinkmann, B. H., Vella, A., & Camilleri, M. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2002.282.3.g424 · Cited by 235
Self-citationEfficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults
Gantz, I., Erondu, N., Mallick, M., Musser, B., Krishna, R., Tanaka, W. K., Snyder, K., Stevens, C., Stroh, M. A., Zhu, H., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1806 · Cited by 163 · cited 1×
“[33] reported, in a study of 133 patients, that intranasal PYY3–36 administered preprandially at doses of 200 μg t.”
BackgroundSchirra, J., Wank, U., Arnold, R., Göke, B., & Katschinski, M. (2002) · Gut · doi:10.1136/gut.50.3.341 · Cited by 130
Cited by
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Wang, D., Day, E. A., Townsend, L. K., Djordjevic, D., Jørgensen, S. B., & Steinberg, G. R. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00529-7 · Cited by 516
Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys
Xiong, Y., Walker, K., Min, X., Hale, C., Tran, T., Komorowski, R., Yang, J., Davda, J., Nuanmanee, N., Kemp, D., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8732 · Cited by 236
“Vagal efferent and afferent signals play important roles in postprandial gastric emptying (20, 21), so we further tested GDF15 in mice after bilateral subdiaphragmatic vagotomy.”
King, N. A., Horner, K., Hills, A. P., Byrne, N. M., Wood, R. E., Bryant, E., Caudwell, P., Finlayson, G., Gibbons, C., Hopkins, M., et al. (2012) · British Journal of Sports Medicine · doi:10.1136/bjsm.2010.082495 · Cited by 169
“For example, ghrelin is an orexigenic peptide secreted from the stomach.[74] Increased postprandial ghrelin suppression is associated with reduced appetite.”
BackgroundAcute Exercise and Gastric Emptying: A Meta-Analysis and Implications for Appetite Control
Horner, K. M., Schubert, M. M., Desbrow, B., Byrne, N. M., & King, N. A. (2015) · Sports Medicine · doi:10.1007/s40279-014-0285-4 · Cited by 128
Differences in brain responses between lean and obese women to a sweetened drink
Connolly, L., Coveleskie, K., Kilpatrick, L. A., Labus, J. S., Ebrat, B., Stains, J., Jiang, Z., Tillisch, K., Raybould, H. E., & Mayer, E. A. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12125 · Cited by 38
Metadata
- Authors
- Camilleri, M.
- Venue
- Regulatory Peptides
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 156
- Issue
- 1-3
- Pages
- 24-27
- ISSN
- 0167-0115 (ISSN-L)
- OpenAlex
- W2019935888
- Cited by
- 23
- References
- 7
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peripheral mechanisms in the control of appetite and related experimental therapies in obesity. https://app.cochat.ai/papers/10.1016/j.regpep.2009.04.011
- The paper
- Camilleri, M. (2009). Peripheral mechanisms in the control of appetite and related experimental therapies in obesity. Regulatory Peptides. https://doi.org/10.1016/j.regpep.2009.04.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.